CCRM’s founding industry consortium represents key sectors of the regenerative medicine industry – pharmaceutical, devices, reagents, tools, biomaterials and cell and gene therapies. The industry consortium consists of large multinationals, small-medium enterprises (SME) and emerging biotechnology companies. It provides market knowledge and a ready supply of global receptors for technologies and products generated by CCRM and its partners.
handing card

CCRM Industry Partnership Evolution: Structure, Optimize & Enhance Partner Engagement

Why Now?

CCRM’s investments in process development, manufacturing and company creation are driving the need for an expanded engagement model with our industry network.

Industry Anchor Partners: a select group of major industry/ecosystem players engaged with CCRM to accomplish the shared goal of building new capabilities and/or infrastructure that will benefit the regenerative medicine ecosystem. Our goals for engagement with anchor partners are to drive forward critical projects, tell the story of our success to the broader community, and create a long-term plan for continued partnership. Cytiva is CCRM’s main industry anchor partner. Cytiva is CCRM’s leading technology development partner, committing $20M to seed the Centre for Advanced Therapeutic Cell Technologies (CATCT) and later providing an additional $15M. This partnership has established product and process development capabilities that serve a critical need in the regenerative medicine ecosystem. OmniaBio Inc., a subsidiary of CCRM, was first announced in March 2022 and celebrated the beginning of construction in October 2022. It will be Canada’s largest CDMO for cell and gene therapies, enabling Phase I to commercial-scale manufacturing of gene-modified cells and viral vectors. OmniaBio will catalyze life sciences jobs and innovation in Ontario.
cytiva-logo
Industry Premier Partners: companies actively engaged with CCRM in significant contract service work for product and process development and/or manufacturing, as well as companies in which CCRM currently holds equity stakes. Our goals for engagement with premier partners are to deliver high-quality, reputation-building services, explore new ways our commercialization platform can grow their business by better understanding their needs, and partner for the advancement of new therapies/tools.
IC-fullmember_0000s_0024_aspect
Empirica Tx Logo
Endogena Therapeutics
External link to ExCellThera
Feldan Therapeutics
Kisoji Biotechnology
LineaBio logo
Mesentech
Morophocell Technologies
Notch Therapeutics

Industry Spotlight Partners: companies that maintain a business relationship with CCRM by sponsoring our events (e.g. annual Till and McCulloch Meetings), engaging in contract service work or partnering on critical projects to support the broader community. Our goals for engagement with spotlight partners are to offer high-quality services, look for opportunities to increase engagement, and provide increased visibility for these companies in the regenerative medicine ecosystem.

* CCRM Australia Industry Network Member

10X Genomics Logo Square
Agilent Logo Square
IC-fullmember_0000s_0016_amgen
Australian Red Cross
External link to AVROBIO
Axion BioSystems logo
IC-fullmember_0000s_0021_bd
Beckman Coulter Life Sciences
Bio-techne
BioLegend Logo Square
BioSpherix Medical Logo Square
BlueRock Therapeutics
Cedarlane Labs Logo Square
Cynata Therapeutics
Eppendorf Canada
FroggaBio Logo Square
IC-associate-_0000s_0016_milenyi
Morophocell Technologies
IC-associate-_0000s_0017_Layer 1
IC-fullmember_0000s_0009_pall
PeproTech Logo Square Small
IC-fullmember_0000s_0011_pfizer
Regeneus logo
ReNerve logo
IC-fullmember_0000s_0007_replicel
Roche Logo Square
SCREEN Logo Square
IC-fullmember_0000s_0005_sernova
Sony Logo Square
IC-associate-_0000s_0003_spiber
IC-fullmember_0000s_0012_stemcell
IC-associate-_0000s_0004_steminent
Terumo BCT Logo Square
IC-fullmember_0000s_0020_thermo fisher
Industry Ecosystem Partners: a diverse and expanding cohort of companies who are interested in learning about regenerative medicine and finding opportunities to boost interactions within the community. Our goals for engagement with ecosystem partners are to stay connected, provide information about CCRM’s activities and others within the community, and facilitate engagement with the broader regenerative medicine ecosystem.
External link to Applikon Biotechnology
IC-fullmember_0000s_0015_athersys
AxcelonBiopolymers
IC-fullmember_0000s_0010_betalogics
IC-associate-_0000s_0013_biocision
IC-associate-_0000s_0005_bca
CellCan Regenerative Medicine
IC-associate-_0000s_0012_cellscale
CompassBiomedical
IC-fullmember_0000s_0019_M
IC-fullmember_0000s_0002_hemostemix
Bilingual_Insception_logo
IC-fullmember_0000s_0013_interface
IC-associate-_0000s_0001_invetech
IC-associate-_0000s_0000_medinet
IC-fullmember_0000s_0023_northern
octane
OriGen Biomedical Logo Small
PDCI
IC-fullmember_0000s_0014_promorigen
External link to Progenics Cord Blood Cryobank
IC-fullmember_0000s_0007_replicel
sartorius
IC-associate-_0000s_0003_spiber
IC-associate-_0000s_0004_steminent
IC-associate-_0000s_0009_syngen
IC-fullmember_0000s_0020_thermo fisher
IC-fullmember_0000s_0017_trt
IC-fullmember_0000s_0014_vistagen